Skip to content

SOHO 2026 abstract submission is now open
Triplet therapy shows efficacy, tolerability, and transplant potential in BPDCN
FDA approves larger Nelarabine vial size for T-ALL and T-LBL
Smoldering MM trends data show increased incidence in certain patient populations
Dr. Kamdar presents, ‘Expanding access to CAR T-cell therapy outside academic centers’

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Elias Jabbour, MD

Cellular Therapy

Elias Jabbour, MD

Leukemia

Elias Jabbour, MD

Lymphoma

Elias Jabbour, MD

Multiple Myeloma

Elias Jabbour, MD

Myelodysplastic Syndromes

Elias Jabbour, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

February 6, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Elias Jabbour, MD

Elias Jabbour, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
434 Views
1 year ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Aggressive B-Cell Lymphomas, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, T-Cell Lymphoma, News

SOHO 2026 abstract submission is now open

February 5, 2026

hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test

ASH 2025

Triplet therapy shows efficacy, tolerability, and transplant potential in

February 4, 2026

Update

Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, T-Cell Lymphoma, News

FDA approves larger Nelarabine vial size for T-ALL and

February 4, 2026

Smoldering Multiple Myeloma Incidence Trends

Multiple Myeloma, Myeloproliferative Neoplasms, News

Smoldering MM trends data show increased incidence in certain

February 3, 2026

Past Sessions, Trending now, Community Oncology, Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, News, Video Interviews

Dr. Kamdar presents, ‘Expanding access to CAR T-cell therapy

February 3, 2026

SOHO Israel

Ambassador Program, News, Society Updates

Registration is open for 4th SOHO Israel Annual Meeting

February 2, 2026

Top Categories

Cellular Therapy

46

Leukemia

79

Lymphoma

83

Multiple Myeloma

74

Myelodysplastic Syndromes

27

Myeloproliferative Neoplasms

17

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Elias Jabbour, MD

Cellular Therapy

Elias Jabbour, MD

Leukemia

Elias Jabbour, MD

Lymphoma

Elias Jabbour, MD

Multiple Myeloma

Elias Jabbour, MD

Myelodysplastic Syndromes

Elias Jabbour, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

SOHO 2026 abstract submission is now open

hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test

Triplet therapy shows efficacy, tolerability, and transplant potential in BPDCN

Update

FDA approves larger Nelarabine vial size for T-ALL and T-LBL

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.